Clinical Trial Update: Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia [Phase 2, Phase 3]

View source ↗

Summary

Pfizer conducted a Phase 2/3 trial comparing azithromycin plus chloroquine to sulfadoxine-pyrimethamine plus chloroquine for uncomplicated Falciparum malaria in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Azithromycin (azithromycin)
• Chloroquine (chloroquine)
• Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Pfizer | Conditions: Malaria, Falciparum | Phase 2, Phase 3 | Status: TERMINATED